补肾促排卵汤治疗体外受精-胚胎移植助孕的PCOS肾虚证患者的临床研究

郭银华; 童星丽; 谈勇

补肾促排卵汤治疗体外受精-胚胎移植助孕的PCOS肾虚证患者的临床研究

1.
南京中医药大学附属医院/江苏省中医院，江苏南京 210029
2.
南京中医药大学第一临床医学院，江苏南京 210023

计量
- 文章访问数: 621
- HTML全文浏览量: 2
- PDF下载量: 468
- 被引次数: 0
出版历程
- 刊出日期: 2020-07-10

Clinical Study of Bushen Cupailuan Decoction in the Treatment of Polycystic Ovarian Syndrome Patients with Kidney Deficiency Symptom in vitro Fertilization-Embryo Transfer

1.
The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China
2.
The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

摘要

摘要: 目的观察补肾促排卵汤对体外受精-胚胎移植（IVF-ET）助孕的多囊卵巢综合征（PCOS）肾虚证患者的临床疗效及对血清性激素水平的影响。方法入组50例行黄体期长方案IVF-ET助孕的PCOS肾虚证患者，其中治疗组和对照组各25例，治疗组使用补肾促排卵汤及生活指导3个周期后进入黄体期长方案IVF-ET周期，对照组生活指导3个周期后进入黄体期长方案IVF-ET周期。观察治疗组及对照组干预前后血清抗苗勒管激素（AMH）、睾酮（T）、促黄体生成素（LH）、体质量指数（BMI）、痤疮及多毛积分、中医证候积分的变化；比较IVF-ET结束后2组的获卵数、促性腺激素（GN）总量、GN天数、双原核受精（2PN）率、2PN卵裂率、优质胚胎率、中重度卵巢过度刺激综合征（OHSS）发生率、冻胚移植（FET）临床妊娠率以及早期流产率。结果治疗组经过治疗后，血清AMH、T、LH水平较治疗前明显下降，痤疮多毛积分与治疗前比较明显好转，中医证候积分较治疗前明显下降，均有统计学差异（P<0.01）。治疗组GN天数及GN总量低于对照组，治疗组2PN率、卵裂率、优质胚胎率高于对照组，均具有统计学意义（P<0.01）。治疗组OHSS发生率低于对照组，FET临床妊娠率高于对照组，早期流产率低于对照组，有统计学差异（P<0.05）。结论补肾促排卵汤可有效改善PCOS患者基础内分泌激素，改善卵子质量，提高优质胚胎率，提高临床妊娠率及降低流产率，降低GN使用天数及总量，降低OHSS发生率。
- 补肾促排卵汤 /
- 多囊卵巢综合征 /
- 抗苗勒管激素 /
- 体外受精-胚胎移植
Abstract: OBJECTIVE To observe the clinical effect of Bushen Cupailuan decoction on polycystic ovarian syndrome (PCOS) patients with kidney deficiency symptom in vitro fertilization-embryo transfer (IVF-ET). METHODS 50 PCOS patients with kidney deficiency symptom who were given long protocol in luteal phase with IVF-ET were enrolled. They were divided into the treatment group and the control group， with 25 cases each group. The treatment group was given Bushen Cupailuan decoction and life guidance for three cycles， followed by the cycle of long protocol in luteal phase with IVF-ET. The control group was given a three-cycle life guidance before the cycle of long protocol in luteal phase with IVF-ET. The serum anti-mullerian hormone (AMH)， testosterone (T)， luteinizing hormone (LH)， body mass index (BMI)， acne and hirsutism score， and traditional Chinese medicine (TCM) syndrome score in the two groups were observed. After IVF-ET， the number of ovums harvested， total gonadotropin (GN)， GN days， 2PN rate， 2PN cleavage rate， high qualified embryo rate， moderate and severe ovarian hyperstimulation syndrome (OHSS) rate， frozen embryo transfer (FET) clinical pregnancy rate and early miscarriage rate were compared. RESULTS After treatment， as for the treatment group， the levels of serum AMH， T， LH and TCM syndrome score decreased significantly compared with levels before treatment. The acne and hirsutism scores in the treatment group were improved significantly compared with those before treatment. The GN days and total GN were lower than those in the control group. The 2PN rate， cleavage rate， and high qualified embryo rate were higher than those in the control group， which had statitistical differences (P<0.01). The incidence of OHSS was lower than that in the control group. The clinical pregnancy rate of frozen embryo transplantation was higher than that in the control group， and the early miscarriage rate was lower than that in the control group (P<0.05). CONCLUSION In terms of PCOS patients， Bushen Cupailuan decoction can effectively improve the basic endocrine hormones， ovum quality， the embryonic rate and the clinical pregnancy rate. In addition， it can reduce the miscarriage rate， the number of days and total amount of gonadotropins and the incidence of OHSS.
- Bushen Cupailuan decoction /
- polycystic ovary syndrome /
- anti-mullerian hormone /
- in vitro fertilization embryo transfer

HTML全文

参考文献(21)

[1]	崔琳琳，陈子江．多囊卵巢综合征诊断标准和诊疗指南介绍[J]．国际生殖健康/计划生育杂志，2011，30(5)：405-408．
[2]	朱文锋．中医诊断学[M]．北京：中国中医药出版社，2002:194-195.
[3]	谈勇．中医妇科学[M]．北京：中国中医药出版社，2004:282-287.
[4]	Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology． The Istanbul consensus workshop on embryo assessment：Proceedings of an expert meeting[J]．Hum Reprod，2011，26(6)：1270-1283．
[5]	LI Y，MA Y，CHEN XH，et al．Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism[J]． J Assist Reprod Genet，2012，29(10)：1147-1151．
[6]	FLUHR JW， DEGITZ K. Antibiotics， azelaic acid and benzoyl peroxide in topical acne therapy[J]. J Dtsch Dermatol Ges，2010，8(S1):S24-S30.
[7]	LONG WQ， RANCHIN V， PAUTIER P， et al. Detection of minimal levels of serum anti-müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay[J]. J Clin Endocrinol Metab， 2000， 85(2):540-544.
[8]	SEIFER DB， MACLAUGHLIN DT， CHRISTIAN BP， et al. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles[J]. Fertil Steril， 2002， 77(3):468-471.
[9]	侯延庆，叶元.血清抗苗勒管激素水平在多囊卵巢综合征的临床意义[J].国际检验医学杂志，2013，34(1):9-10.
[10]	MORAN LJ， HARRISON CL， HUTCHISON SK， et al. Exercise decreases anti-Müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: A pilot study[J]. Horm Metab Res，2011， 43(13): 977-979．
[11]	CATTEAU-JONARD S， PIGNY P， REYSS AC， et al．Changes in serum antimullerian hormone level during low-dose recombinant follicularstimulating hormone therapy for anovulation in polycystic ovary syndrome[J]. J Clin Endocrinol Metab， 2007， 92(11): 4138-4143．
[12]	GRUIJTERS MJ， VISSER JA， DURLINGER AL， et al. Anti-Müllerian hormone and its role in ovarian function[J]. Mol Cell Endocrinol， 2003， 211(1/2): 85-90.
[13]	QIAO J， FENG HL. Extra and intraovarian factors in polycystic ovary syndrome: Impact on oocyte maturation and embryo developmental competence [J]. Hum Reprod Update， 2011， 17(1): 17-33.
[14]	HAZOUT A， BOUCHARD P， SEIFER DB， et al. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone， inhibin B， or estradiol[J]. Fertil Steril， 2004， 82(5):1323-1329.
[15]	郭银华，谈勇，邹奕洁，等．补肾促排卵汤联合枸橼酸氯米芬片治疗多囊卵巢综合征所致不孕症及妊娠结局临床观察[J]．湖北中医药大学学报，2013，15(6)：53-54．
[16]	郭银华．补肾促排卵汤对多囊卵巢综合征排卵功能障碍性不孕症干预机制的研究[D]．南京：南京中医药大学，2016．
[17]	BHIDE P，GUDI A，SHAH A，et al．Anti-müllerian hormone as a predictor of pregnancy following IVF[J]．Reprod Biomed Online，2013，26(3)：247-252．
[18]	李曼，温冬梅，王伟佳，等．AMH、FSH、LH、E₂联合检测在不孕症患者卵巢储备功能中的预测价值[J]．检验医学与临床，2017，14(12)：1729-1731．
[19]	孙静，熊晓英，齐国华，等．血清抗苗勒管激素水平与多囊卵巢综合征激素特征关系的研究[J]．海南医学，2009，20(6)：21-22，31．
[20]	袁利，程明刚，刘香萍，等．深圳地区健康育龄妇女血清中AMH水平现况及其在PCOS和POF诊疗中的价值[J]．现代检验医学杂志，2017，32(5)：141-144．
[21]	万启军，张颖，杨悌．多囊卵巢综合征患者抗苗勒氏管激素、睾酮和胰岛素抵抗相关性的临床研究[J]．中国血液流变学杂志，2017，27(3)：320-322．